莫创骑徐立卢明.依达拉奉治疗急性脑出血的临床疗效及对血浆MMP-9水平的影响[J].现代生物医学进展英文版,2011,11(2):297-299. |
依达拉奉治疗急性脑出血的临床疗效及对血浆MMP-9水平的影响 |
MMP-9 changes after acute intracerebral hemorrhage and interventionstudy with edaravone injection |
|
DOI: |
中文关键词: 依达拉奉 脑出血 MMP-9 |
英文关键词: edaravone acute intracerebral hemorrhage MMP-9 |
基金项目: |
|
Hits: 687 |
Download times: 1372 |
中文摘要: |
目的:观察依达拉奉治疗急性脑出血的临床疗效和对血浆基质金属蛋白酶-9(MMP-9)水平的影响。方法:60例急性脑出血
患者随机分为治疗组和对照组各30 例。对照组给予常规治疗,治疗组在对照组治疗基础上加用依达拉奉,并在治疗后24h 内和
14d进行神经功能缺损评分及血浆MMP-9水平测定。结果:治疗组神经功能缺损评分、血浆MMP-9水平较对照组降低(P<0.05、
P <0.01)。结论:依达拉奉可改善急性脑出血患者神经功能,可能与降低MMP-9水平有关。 |
英文摘要: |
Objective: To observe the clinical efficacy of edaravone for acute intracerebral hemorrhage and its impact on serum
content of MMP-9. Methods: A total of 60 patients were enrolled : 30 (control group) were randomly assigned to receive routine therapy
alone, and 30 (trial group) to receive routine therapy plus edaravone. The nerve f unction deficiency scores, serum content of MMP-9
were compared 14d before and after treatment. Results: In the trial group as compared with the control group, the nerve function deficiency
scores were obviously lower ( P < 0.05), and serum content of MDA was significantly lower (P <0.05). Conclusions: Edaravone can
obviously improve the nerve function of patients with acute Intracerebral Hemorrhage, this may be attributed to the low content of
MMP-9. |
View Full Text
View/Add Comment Download reader |
Close |